1. Turkyilmaz, Ayberk, Saglam, Kubra Adanur, Yilmaz, Mustafa, Cebi, Alper Han. 2024. A Strong Candidate Gene for Nonsyndromic Intellectual Disability Phenotype: SGSM3. In Clinical genetics, 107, 196-200. doi:10.1111/cge.14631. https://pubmed.ncbi.nlm.nih.gov/39390489/
2. Jung, Seung Eun, Choi, Jung-Won, Moon, Hanbyeol, Kim, Sang Woo, Hwang, Ki-Chul. 2020. Small G protein signaling modulator 3 (SGSM3) knockdown attenuates apoptosis and cardiogenic differentiation in rat mesenchymal stem cells exposed to hypoxia. In PloS one, 15, e0231272. doi:10.1371/journal.pone.0231272. https://pubmed.ncbi.nlm.nih.gov/32271805/
3. Birnbaum, Rivka, Ezer, Shlomit, Lotan, Nava Shaul, Harel, Tamar, Mor-Shakad, Hagar. 2024. Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews. In Journal of medical genetics, 61, 289-293. doi:10.1136/jmg-2023-109504. https://pubmed.ncbi.nlm.nih.gov/37833060/
4. Tan, Tan, Zhang, Kai, Chen, Wenjun. 2016. Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population. In Breast cancer (Tokyo, Japan), 24, 369-374. doi:10.1007/s12282-016-0712-5. https://pubmed.ncbi.nlm.nih.gov/27432265/
智鼠故事 
